Carole Ho, Chief Medical Officer: Denali Therapeutics DNLI Sell · Filed 24/01/12

Trade details

Type: Insider sale
Amount: $88,785.36
Shares · price: 4,668 sh · $19.02 a share
Held after: 147,794 sh
Stock: Denali Therapeutics DNLI
Person: Carole HoChief Medical Officer
Trade date: 24/01/10
Filed: 24/01/12
Days to filing: 2 days

Sold 3.1% of holdings

Share of holding sold: 3.1%

Denali Therapeutics trades, last 26 weeks

What else happened in Denali Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/11~24/02/09

Carole Ho's recent trades

Carole HoDirector
Planned saleBeam Therapeutics
Planned sale
Beam Therapeutics
BEAM
$2.7M
87,784 sh
$2.7M
Filed 04/14
Traded 04/14
Carole HoFormer Affiliate
Planned saleDenali Therapeutics
Planned sale
Denali Therapeutics
DNLI
$801.4K
39,490 sh
$801.4K
Filed 02/05
Traded 02/05
Carole HoFormer Affiliate
Planned saleDenali Therapeutics
Planned sale
Denali Therapeutics
DNLI
$3.2M
150,000 sh
$3.2M
Filed 02/04
Traded 02/04
Carole HoFormer Affiliate
Planned saleDenali Therapeutics
Planned sale
Denali Therapeutics
DNLI
$3.3M
150,000 sh
$3.3M
Filed 02/03
Traded 02/03
Carole HoConsultant
Planned saleDenali Therapeutics
Planned sale
Denali Therapeutics
DNLI
$284.1K
17,218 sh
$284.1K
Filed 01/06
Traded 01/06